Treatment arrives for secondary progressive MS. Siponimod has been approved by the FDA in the US.
This can be used from clinically.isolated syndrome onwards.
So why would you want fingolimod?
I wonder. They work the same way but siponimod may have lesser side effects.
What will NICE do? keep it second.line like fingolimod or.give it a first line licence. I guess it depends on what the EMA say
Biologically there has never been a reason for this. Likewise if it works for spms it should work for ppms, but is licenced for spms
Fingo has little patent life left I wonder if this was pulled could the generics arrive?
The mod wars have begun expect more …imods to come your way